Announcement on Convening the Q1 2026 Performance Briefing
Filed with SSE · · 2 pages · Chinese
BrightGene Bio-Medical Technology Co. Ltd. on 6ix
Earlier from BrightGene Bio-Medical Technology
- The 6th Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"
- The 5th Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"
- The 4th Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"
- The 3rd Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"
- The 2nd Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"
Later from BrightGene Bio-Medical Technology
- The 8th Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"
- The Last Indicative Announcement on the Redemption and Delisting of "BrightGene Convertible Bonds"
- Announcement on Redemption Results of "BrightGene Convertible Bonds" and Share Changes
- Announcement on Resignation of Directors and Secretary of the Board of Directors
- Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
Follow BrightGene Bio-Medical Technology into a list and get an email when it puts out news.
Follow BrightGene Bio-Medical Technology